Clinical Trial Update: Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial of QGC001 evaluating single-dose and multiple-dose oral administration in healthy adults for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• QGC001

Snippet

Sponsor: Quantum Genomics SA | Conditions: Essential Hypertension | Phase 1 | Status: COMPLETED